ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2018-11-14
What ALLIED HEALTHCARE PRODUCTS, INC. reported in its quarterly report filed 2018-11-14 (fiscal Q1 2019): 29 published measures, 60 facts as tagged in accession 0001144204-18-059714.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2018-11-14
- Fiscal period
- fiscal Q1 2019
- Accession
- 0001144204-18-059714 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALLIED HEALTHCARE PRODUCTS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 17,111,054 | USD | |
| At 2018-06-30 | 17,321,241 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 12,763,105 | USD | |
| At 2018-06-30 | 13,996,940 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 800 | USD | |
| At 2018-06-30 | 136,112 | USD | |
| At 2017-09-30 | 244,250 | USD | |
| At 2017-06-30 | 995,704 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -1,234,575 | USD | 92 |
| 2017-07-01 to 2017-09-30 | -767,236 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -513,272 | USD | 92 |
| 2017-07-01 to 2017-09-30 | -751,454 | USD | 92 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 7,268,897 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 7,896,853 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 377,960 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 0 | USD | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 0 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 4,604,046 | USD | |
| At 2018-06-30 | 4,823,149 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 740 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 645 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -1,226,317 | USD | 92 |
| 2017-07-01 to 2017-09-30 | -767,399 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 11,986,345 | USD | |
| At 2018-06-30 | 11,977,429 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 8,288 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 0 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 4,347,949 | USD | |
| At 2018-06-30 | 3,324,301 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 2,030,059 | USD | |
| At 2018-06-30 | 1,473,618 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 3,203,422 | USD | |
| At 2018-06-30 | 3,747,993 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 8,551,678 | USD | |
| At 2018-06-30 | 7,830,541 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 878,826 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 1,357,069 | USD | 92 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 2,105,143 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 2,124,468 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 4,013,537 | shares | |
| At 2018-06-30 | 4,013,537 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | -14,797,206 | USD | |
| At 2018-06-30 | -13,562,631 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-09-30 | 1,939,930 | USD | |
| At 2018-06-30 | 1,850,683 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -1,234,575 | USD | 92 |
| 2017-07-01 to 2017-09-30 | -767,236 | USD | 92 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 219,103 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 240,553 | USD | 92 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 0 | USD | 92 |
| 2017-07-01 to 2017-09-30 | -52 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -8,258 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 163 | USD | 92 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | -543,585 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 73,034 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 721,137 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 621,959 | USD | 92 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-07-01 to 2018-09-30 | 556,441 | USD | 92 |
| 2017-07-01 to 2017-09-30 | 128,404 | USD | 92 |
Inspect the source
- Entity
- ALLIED HEALTHCARE PRODUCTS, INC. / CIK 0000874710
- Captured
- SEC response SHA-256
f694204a453d7f425517aaaf1b9247d581a7c239a0c125906f119959cddf46dc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000874710.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))